The effect of intravitreal bevacizumab injection on the corneal endothelial cells
Introduction:Bevacizumab (Avastin), as an effectiveness treatment modality, is currently used in patients with various ocular disease. However the results have been promising, the use of bevacizumab in the treatment of ocular disease is an off-label application. Hence, the aim of this study was to s...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2016-04-01
|
Series: | Reviews in Clinical Medicine |
Subjects: | |
Online Access: | http://rcm.mums.ac.ir/article_6403_cb68d270c67df82f91f6d8d4a62597c5.pdf |